Tenofovir Disoproxil Fumarate
Open Access
- 1 October 2003
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 37 (7), 944-950
- https://doi.org/10.1086/378068
Abstract
Tenofovir disoproxil fumarate (tenofovir DF) is a bioavailable prodrug of tenofovir, a potent nucleotide analogue reverse-transcriptase inhibitor witKeywords
This publication has 14 references indexed in Scilit:
- Tenofovir Disoproxil Fumarate in Nucleoside-Resistant HIV-1 InfectionAnnals of Internal Medicine, 2003
- Determining the antiviral activity of tenofovir disoproxil fumarate in treatment-naive chronically HIV-1-infected individualsAIDS, 2003
- Tenofovir‐Related Nephrotoxicity in Human Immunodeficiency Virus–Infected Patients: Three Cases of Renal Failure, Fanconi Syndrome, and Nephrogenic Diabetes InsipidusClinical Infectious Diseases, 2003
- Tenofovir Disoproxil Fumarate in Patients with HIV and Lamivudine-Resistant Hepatitis B VirusNew England Journal of Medicine, 2003
- Molecular Mechanisms of Resistance to Human Immunodeficiency Virus Type 1 with Reverse Transcriptase Mutations K65R and K65R+M184V and Their Effects on Enzyme Function and Viral Replication CapacityAntimicrobial Agents and Chemotherapy, 2002
- ATP-Dependent Removal of Nucleoside Reverse Transcriptase Inhibitors by Human Immunodeficiency Virus Type 1 Reverse TranscriptaseAntimicrobial Agents and Chemotherapy, 2002
- Tenofovir DF in antiretroviral-experienced patients: results from a 48-week, randomized, double-blind studyAIDS, 2002
- Tenofovir Diphosphate Is a Poor Substrate and a Weak Inhibitor of Rat DNA Polymerases α, δ, and ε*Antimicrobial Agents and Chemotherapy, 2002
- Assessment of Mitochondrial Toxicity in Human Cells Treated with Tenofovir: Comparison with Other Nucleoside Reverse Transcriptase InhibitorsAntimicrobial Agents and Chemotherapy, 2002
- Phase I/II Trial of the Pharmacokinetics, Safety, and Antiretroviral Activity of Tenofovir Disoproxil Fumarate in Human Immunodeficiency Virus-Infected AdultsAntimicrobial Agents and Chemotherapy, 2001